Adaptimmune Therapeutics PLC Annual Costs and Expenses in USD from 2013 to 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Adaptimmune Therapeutics PLC quarterly/annual Costs and Expenses history and growth rate from 2013 to 2024.
  • Adaptimmune Therapeutics PLC Costs and Expenses for the quarter ending December 31, 2024 was $76.7M, a 53.2% increase year-over-year.
  • Adaptimmune Therapeutics PLC Costs and Expenses for the twelve months ending December 31, 2024 was $247M, a 23.4% increase year-over-year.
  • Adaptimmune Therapeutics PLC annual Costs and Expenses for 2024 was $247M, a 23.4% increase from 2023.
  • Adaptimmune Therapeutics PLC annual Costs and Expenses for 2023 was $200M, a 4.66% increase from 2022.
  • Adaptimmune Therapeutics PLC annual Costs and Expenses for 2022 was $191M, a 13.5% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $247M +$46.8M +23.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $200M +$8.91M +4.66% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $191M +$22.7M +13.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-24
2021 $168M +$31M +22.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $137M -$3.53M -2.51% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $141M -$978K -0.69% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-14
2018 $142M +$23.4M +19.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $118M +$31.5M +36.2% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-27
2016 $87M +$52.5M +152% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $34.5M +$22.2M +180% Jul 1, 2014 Jun 30, 2015 10-K 2018-03-15
2014 $12.3M +$3.6M +41.1% Jul 1, 2013 Jun 30, 2014 10-K 2017-03-13
2013 $8.75M Jul 1, 2012 Jun 30, 2013 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.